• Skip to primary navigation
  • Skip to main content
  • Skip to footer
AKRN

AKRN

Scientific Consulting

  • Services
    • Clinical Services
    • Regulatory Services
    • Quality Management Services
    • Medical Writing
    • Clinical Data Management
    • Statistical Analysis and Reporting
    • Medical Aesthetic Devices
    • COVID-19
  • Team
    • Who we are
    • Our team
    • Code of Ethics
    • Our history
    • Our Community
  • News
    • News
    • Resources
    • Social Network
  • Career Portal
  • Contact
  • English
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

ISO 20916 for IVD vs. ISO 14155 for Medical Devices

December 17, 2020 by AKRN

The ISO 20916 is specific for in-vitro diagnostic (IVD) medical devices


The ISO 20916 was released in 2019 and uses definitions and concepts appropriate for IVDs. It is a stand-alone standard for clinical performance studies for IVD medical devices.

Purpose of ISO 20916

The initial efforts to develop ISO 20916 built on synergies with the GCP standard for clinical investigation of medical devices in human subjects, ISO 14155. Nonetheless, the intended purpose of IVDs is distinct from that of medical devices and many concepts are different between the two standards. IVDs utilize specimens taken from the human body for diagnosis or monitoring. The potential harm and risk to the patient associated with IVD devices are generally related to erroneous results obtained from the device or collection procedures, rather than to the device itself. 

ISO 20916 is intended to provide requirements and guidance for the execution of IVD clinical performance studies (CPS). Clinical performance studies shall be conducted in a manner in which every precaution has been taken to protect the rights and the health and safety of the subject, user and other persons, considering all regulatory and ethical requirements, and using valid scientific principles.

  • Ethical and regulatory considerations
  • Study design and planning
  • Informed consent process
  • Site initiation, conduct, and close out
  • Site monitoring and data quality
  • Adverse event reporting 

The standard is structured to accommodate clinical performance studies on all types of IVDs and takes into account that the design of the clinical performance studies will depend on:

  • Test samples (e.g. fresh samples, leftover, or archived specimens)
  • Study objectives (i.e. results will influence patient management decisions)
  • Study design (i.e. procedure will present additional risk of direct harm for the subject)

Clinical performance of an IVD medical device 

The clinical performance measures the ability of an IVD medical device to yield results that are correlated with a particular clinical condition or physiological/pathological process/state in accordance with the intended use (clinical test purpose, target population and intended user). In accordance with intended use, clinical performance can include expected values, diagnostic sensitivity and diagnostic specificity based on the known clinical condition or physiological/pathological process/state of the individual, and negative and positive predictive values based on the prevalence of the disease.


Clinical performance studies

How to collect clinical evidence compliant with IVDR 

According to the IVDR, clinical evidence must support the device’s intended purpose as stated by the manufacturer and be based on a continuous process of performance evaluation, following a performance evaluation plan (PEP). The clinical evidence is presented in a performance evaluation report (PER) that should demonstrate the following elements.

  • Scientific validity
  • Analytical performance
  • Clinical performance

If a clinical performance study is executed, it should be correctly presented in a clinical performance study report (CPSR), including the study plan and results, and conclusions. A summary of CPSR is presented in the performance evaluation report (PER) as support of the clinical performance requirement. 


How to design clinical performance studies

Clinical performance studies are the studies undertaken to establish or confirm an IVD medical device’s clinical performance. The purpose of clinical performance studies is to verify or confirm aspects of device performance that cannot be determined by analytical performance studies, literature, and/or previous experience gained by routine diagnostic testing. This information is used to demonstrate compliance with relevant general safety and performance requirements. The data obtained from clinical performance studies are used in the performance evaluation process as a part of the clinical evidence for the IVD.

Types of clinical performance study 

An observational (non-interventional) study refers to a study in which test results obtained during the study are not used for patient management and do not impact treatment decisions.

  • Observational study
  • Interventional study

An interventional study refers to a study in which test results obtained during the study may influence patient management decisions and may be used to guide treatments. An interventional design would be appropriate if an observational clinical performance study cannot demonstrate performance claims for an IVD medical device.  

Clinical validity is a test’s ability to accurately and reliably predict the clinically defined disorder of interest.

Clinical utility is the ability of a test to implicitly improve patient health outcomes when used to inform and support clinical decisions that increase the chances of improved patient outcomes

Clinical validity studies consist of the following test parameters:

  • Clinical Sensitivity: The percentage of individuals with the target condition (disease) that will have positive test results
  • Clinical Specificity: The percentage of individuals that do not have the target condition who will have negative test results
  •  Positive Predictive Value: The proportion of individuals in the intended use populations who have the target condition
  •  Negative Predictive Value: The proportion of individuals in the intended use populations who do not have the target condition

Clinical utility studies should measure the following outcomes:

  • Assess potential benefits and harms of testing from the patient perspective
  • Consider that outcomes may occur at different time points and result from clinical management decisions guided by test results
  • Include clinical assessments of disease remission and progression, response to therapy, functional status, and adverse events

Pre-market testing that has not been specifically designed to address the clinical performance of an IVD medical device (e.g. customer feedback studies, external analytical performance studies, research studies) shall not be considered a clinical performance study.

Clinical performance studies shall be carried out using product representative of the final manufactured IVD medical device intended for commercialization. It is mandatory to use controlled and accepted processes and procedures, even though scale up might not yet be completed.

Clinical performance studies shall be undertaken under an effective quality management system to ensure that the ISO 20916 principles are fulfilled. The study sponsor shall take responsibility for ensuring that these principles are met.

The team at AKRN Scientific Consulting can perform one or more of the sponsor’s clinical performance study-related duties and functions. Please contact us if you need support with the initiation, implementation and oversight of a clinical performance study.

Subject Matter Experts

Maria Nyåkern, Ph.D. Founder & Executive Director LinkedIn

Diana Posa, Pharm.D Associate Director Clinical Affairs LinkedIn

Share this article

Category iconCE Mark,  Clinical Trial,  European Union,  ISO 14155,  IVD,  IVDR,  Uncategorized Tag iconCE mark,  IVDR,  IVDs,  Medical Devices

Request a free consultation

Our team will help you to find the best solution for your needs. Our medical device experience and clinical knowledge can help you plan, set up, and execute a clinical trial, or performance study, in an optimal way.

Footer

AKRN Spain

AKRN Scientific Consulting S.L.
Address: Calle de Fuerteventura 4 (office 1.8)
Office Park La Marina
Postal Code: ES-28703 Madrid
Phone: +34 910 25 81 40
VAT ID: ES-B87990925

Contact details

Contact email: contact@akrnconsulting.com
Office phone: +34 910 258 140
Office phone: +34 911 136 635
Go to contact

Content

  • Medical Device Consulting Services
  • Clinical Studies for Medical Devices
  • Medical Writing
  • Regulatory Services
  • Contact

Resources

  • Articles
  • Resources
  • Career Portal

Latest articles

  • NEW AEMPS INSTRUCTION FOR MANUFACTURING LICENSE
  • DEVELOP AND IMPLEMENT YOUR QMS ACCORDING TO ISO 13485
  • Summary of Safety and Clinical Performance (SSCP/SSP)
  • Essential documents according to ISO 14155:2020
  • Roadmap to CE marking for medical devices and IVDs
  • The quality management system according to ISO 13485

AKRN Scientific Consulting S.L ha sido beneficiaria del Fondo Europeo de Desarrollo Regional cuyo objetivo es mejorar la competitividad de las Pymes y gracias al cual ha puesto en marcha un Plan de Marketing Digital Internacional con el objetivo de mejorar su posicionamiento online en mercados exteriores durante el año 2020. Para ello ha contado con el apoyo del Programa XPANDE DIGITAL de la Cámara de Comercio de Burgos.
“Una manera de hacer Europa”

AKRN Scientific Consulting S.L ha sido beneficiaria de la subvención de contratos de trabajo de la Comunidad de Madrid, cofinanciado por el Fondo Social Europeo y la Iniciativa de Empleo Juvenil, en el marco del Programa Operativo de Empleo Juvenil 2014-2020, gestionado por la Consejería de Economía, Empleo y Hacienda.

La empresa (AKRN Scientific Consulting S.L.) es beneficiaria del Programa “la Caixa” Empleo Joven de ayudas para el fomento de la contratación de personas jóvenes. Estas ayudas están cofinanciadas por el Programa Operativo de Empleo Juvenil / Iniciativa de Empleo Juvenil – Fondo Social Europeo y por la Fundación Bancaria “la Caixa”.

 

 

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Privacy policy – Cookie Policy – Legal Notice –  Copyright © 2022. All rights reserved. Return to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview
AKRN

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy